Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof

Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof

US Patent 11492403 · Granted Nov 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Injection molding to generate complex hydrogel geometries for cell encapsulation2025
T cell receptor constructs and uses thereof2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Neoantigens and uses thereof2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025